Improved wound management at lower cost: a sensible goal for Australia
- PMID: 26634882
- PMCID: PMC7949577
- DOI: 10.1111/iwj.12538
Improved wound management at lower cost: a sensible goal for Australia
Abstract
Chronic wounds cost the Australian health system at least US$2·85 billion per year. Wound care services in Australia involve a complex mix of treatment options, health care sectors and funding mechanisms. It is clear that implementation of evidence-based wound care coincides with large health improvements and cost savings, yet the majority of Australians with chronic wounds do not receive evidence-based treatment. High initial treatment costs, inadequate reimbursement, poor financial incentives to invest in optimal care and limitations in clinical skills are major barriers to the adoption of evidence-based wound care. Enhanced education and appropriate financial incentives in primary care will improve uptake of evidence-based practice. Secondary-level wound specialty clinics to fill referral gaps in the community, boosted by appropriate credentialing, will improve access to specialist care. In order to secure funding for better services in a competitive environment, evidence of cost-effectiveness is required. Future effort to generate evidence on the cost-effectiveness of wound management interventions should provide evidence that decision makers find easy to interpret. If this happens, and it will require a large effort of health services research, it could be used to inform future policy and decision-making activities, reduce health care costs and improve patient outcomes.
Keywords: Australia; Chronic wounds; Cost-effectiveness analysis; Leg ulcer; Wound management.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Conflict of interest statement
The Wound Management Innovation Cooperative Research Centre (WMI CRC) receives funding from the Australian Government, Curtin University of Technology, Queensland University of Technology, Smith & Nephew Proprietary Limited, Southern Cross University, University of South Australia, Australian Wound Management Association Inc., Blue Care, the Department of Health South Australia, the Department of Health Victoria, Ego Pharmaceuticals Pty Ltd, Metropolitan Health Service/Wounds West, Queensland Health, Royal District Nursing Service Limited, Royal Melbourne Institute of Technology, Silver Chain Group, and South East Queensland Hyperbaric Pty Ltd. The funding source played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. All authors declare no conflicts of interest.
Figures


References
-
- Graves N, Zheng H. The prevalence and incidence of chronic wounds: a literature review. Wound Pract Res 2014;22:4–12, 4–9.
-
- Graves N, Zheng H. Modelling the direct health care costs of chronic wounds in Australia. Wound Pract Res 2014;22:20–4, 6–33.
-
- Mulligan S, Prentice J, Scott L. WoundsWest Wound Prevalence Survey 2011: state‐wide overview report. Perth, WA: Ambulatory Care Services, Department of Health, 2011.
-
- Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social and psychologic implications. J Am Acad Dermatol 1994;31:49–53. - PubMed
-
- Scottish Intercollegiate Guidelines Network (SIGN) . Diagnosis and management of peripheral arterial disease: a national clinical guideline. Edinburgh: SIGN, 2006.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources